Patients exhibiting high-stage colorectal adenocarcinoma (CRA) and diffuse IMP3 expression exhibited significantly poorer survival rates (p < 0.0001) compared to those without diffuse IMP3 expression (p = 0.0038). Here, IMP3 is linked to colorectal adenocarcinoma.